Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.
a study on Schizophrenia
Schizophrenia Schizoaffective Disorder Mental Disorders Anti-Dyskinesia Agents Antiparkinson Agents Central Nervous System Agents Dopamine Agents Excitatory Amino Acid Agents Excitatory Amino Acid Antagonists Molecular Mechanisms of Pharmacological Action Neurotransmitter Agents Pharmacologic Actions Physiological Effects of Drugs Therapeutic Uses Prepulse inhibition Neurocognition Working memory Dextroamphetamine MATRICS Consensus Cognitive Battery Pharmacologic Augmentation of Cognitive Therapies Sensory discrimination learning Targeted Cognitive Training rs4680 polymorphism of catechol-O-methyltransferase (COMT) Amphetamine Excitatory Amino Acids
Lead Scientist at UCSD
- Neal R. Swerdlow, M.D., Ph.D.
Biography Neal Swerdlow, M.D., Ph.D. is Professor of Psychiatry, Director of the Research Residency Track and Vice Chair of Education and Training in the Department of Psychiatry at the University of California, San Diego, School of Medicine. Dr. Swerdlow graduated Summa Cum Laude, Phi Beta Kappa, from Amherst College (Neuroscience) in 1981, received his M.D. and Ph.D.
- accepting new patients
- Start Date
- Completion Date
- University of California, San Diego
- Phase 2
- Study Type
- Last Updated